Selected research
Industry Growth & Trends
Global Dementia and Alzheimer’s Disease Treatment Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Dementia and Alzheimer’s Disease Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Dementia and Alzheimer’s Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Dementia and Alzheimer’s Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Dementia and Alzheimer’s Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Dementia and Alzheimer’s Disease Treatment market include Novartis, Eli Lilly and Company, Pfizer, Inc., AbbVie Inc., AstraZeneca, INmuneBIO, F. Hoffmann-La Roche Ltd., Eisai Co., Ltd. and Biogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Dementia and Alzheimer’s Disease Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Dementia and Alzheimer’s Disease Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dementia and Alzheimer’s Disease Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dementia and Alzheimer’s Disease Treatment.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Dementia and Alzheimer’s Disease Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Dementia and Alzheimer’s Disease Treatment Market by Company
Novartis
Eli Lilly and Company
Pfizer, Inc.
AbbVie Inc.
AstraZeneca
INmuneBIO
F. Hoffmann-La Roche Ltd.
Eisai Co., Ltd.
Biogen
Allergan plc
Dementia and Alzheimer’s Disease Treatment Segment by Type
Combination Drugs
Memantine
Cholinesterase Inhibitors
Dementia and Alzheimer’s Disease Treatment Segment by Application
Hospital
Clinic
Dementia and Alzheimer’s Disease Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dementia and Alzheimer’s Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dementia and Alzheimer’s Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dementia and Alzheimer’s Disease Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Dementia and Alzheimer’s Disease Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Combination Drugs
- Memantine
- Cholinesterase Inhibitors
Applications
- Hospital
- Clinic
Companies covered
- Novartis
- Eli Lilly and Company
- Pfizer, Inc.
- AbbVie Inc.
- AstraZeneca
- INmuneBIO
- F. Hoffmann-La Roche Ltd.
- Eisai Co., Ltd.
- Biogen
- Allergan plc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Dementia and Alzheimer’s Disease Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Dementia and Alzheimer’s Disease Treatment Market Size by Region (2021-2032)
- 1.4.1 Global Dementia and Alzheimer’s Disease Treatment Market Size by Region (2021-2026)
- 1.4.2 Global Dementia and Alzheimer’s Disease Treatment Market Size by Region (2027-2032)
- 1.5 Key Regions Dementia and Alzheimer’s Disease Treatment Market Size (2021-2032)
- 1.5.1 North America Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate (2021-2032)
- 1.5.4 South America Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate (2021-2032)
2 Dementia and Alzheimer’s Disease Treatment Market by Type
- 2.1 Type Introduction
- 2.1.1 Combination Drugs
- 2.1.2 Memantine
- 2.1.3 Cholinesterase Inhibitors
- 2.2 Global Dementia and Alzheimer’s Disease Treatment Market Size by Type
- 2.2.1 Global Dementia and Alzheimer’s Disease Treatment Market Size Overview by Type (2021-2032)
- 2.2.2 Global Dementia and Alzheimer’s Disease Treatment Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Dementia and Alzheimer’s Disease Treatment Market Size Forecasted by Type (2027-2032)
- 2.3 Global Dementia and Alzheimer’s Disease Treatment Market Size by Regions
- 2.3.1 North America Dementia and Alzheimer’s Disease Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Dementia and Alzheimer’s Disease Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Dementia and Alzheimer’s Disease Treatment Market Size Breakdown by Type (2021-2026)
3 Dementia and Alzheimer’s Disease Treatment Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.2 Global Dementia and Alzheimer’s Disease Treatment Market Size by Application
- 3.2.1 Global Dementia and Alzheimer’s Disease Treatment Market Size Overview by Application (2021-2032)
- 3.2.2 Global Dementia and Alzheimer’s Disease Treatment Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Dementia and Alzheimer’s Disease Treatment Market Size Forecasted by Application (2027-2032)
- 3.3 Global Dementia and Alzheimer’s Disease Treatment Market Size by Regions
- 3.3.1 North America Dementia and Alzheimer’s Disease Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Dementia and Alzheimer’s Disease Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Dementia and Alzheimer’s Disease Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Dementia and Alzheimer’s Disease Treatment Industry Trends
- 4.2 Dementia and Alzheimer’s Disease Treatment Industry Drivers
- 4.3 Dementia and Alzheimer’s Disease Treatment Industry Opportunities and Challenges
- 4.4 Dementia and Alzheimer’s Disease Treatment Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Dementia and Alzheimer’s Disease Treatment Revenue (2021-2026)
- 5.2 Global Dementia and Alzheimer’s Disease Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Dementia and Alzheimer’s Disease Treatment Key Company Headquarters & Area Served
- 5.4 Global Dementia and Alzheimer’s Disease Treatment Company, Product Type & Application
- 5.5 Global Dementia and Alzheimer’s Disease Treatment Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Dementia and Alzheimer’s Disease Treatment Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Dementia and Alzheimer’s Disease Treatment Players Market Share by Revenue in 2025
- 5.6.3 2025 Dementia and Alzheimer’s Disease Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Novartis
- 6.1.1 Novartis Company Information
- 6.1.2 Novartis Business Overview
- 6.1.3 Novartis Dementia and Alzheimer’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Novartis Dementia and Alzheimer’s Disease Treatment Product Portfolio
- 6.1.5 Novartis Recent Developments
- 6.2 Eli Lilly and Company
- 6.2.1 Eli Lilly and Company Company Information
- 6.2.2 Eli Lilly and Company Business Overview
- 6.2.3 Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Product Portfolio
- 6.2.5 Eli Lilly and Company Recent Developments
- 6.3 Pfizer, Inc.
- 6.3.1 Pfizer, Inc. Company Information
- 6.3.2 Pfizer, Inc. Business Overview
- 6.3.3 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Product Portfolio
- 6.3.5 Pfizer, Inc. Recent Developments
- 6.4 AbbVie Inc.
- 6.4.1 AbbVie Inc. Company Information
- 6.4.2 AbbVie Inc. Business Overview
- 6.4.3 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Product Portfolio
- 6.4.5 AbbVie Inc. Recent Developments
- 6.5 AstraZeneca
- 6.5.1 AstraZeneca Company Information
- 6.5.2 AstraZeneca Business Overview
- 6.5.3 AstraZeneca Dementia and Alzheimer’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 AstraZeneca Dementia and Alzheimer’s Disease Treatment Product Portfolio
- 6.5.5 AstraZeneca Recent Developments
- 6.6 INmuneBIO
- 6.6.1 INmuneBIO Company Information
- 6.6.2 INmuneBIO Business Overview
- 6.6.3 INmuneBIO Dementia and Alzheimer’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 INmuneBIO Dementia and Alzheimer’s Disease Treatment Product Portfolio
- 6.6.5 INmuneBIO Recent Developments
- 6.7 F. Hoffmann-La Roche Ltd.
- 6.7.1 F. Hoffmann-La Roche Ltd. Company Information
- 6.7.2 F. Hoffmann-La Roche Ltd. Business Overview
- 6.7.3 F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Product Portfolio
- 6.7.5 F. Hoffmann-La Roche Ltd. Recent Developments
- 6.8 Eisai Co., Ltd.
- 6.8.1 Eisai Co., Ltd. Company Information
- 6.8.2 Eisai Co., Ltd. Business Overview
- 6.8.3 Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Product Portfolio
- 6.8.5 Eisai Co., Ltd. Recent Developments
- 6.9 Biogen
- 6.9.1 Biogen Company Information
- 6.9.2 Biogen Business Overview
- 6.9.3 Biogen Dementia and Alzheimer’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Biogen Dementia and Alzheimer’s Disease Treatment Product Portfolio
- 6.9.5 Biogen Recent Developments
- 6.10 Allergan plc
- 6.10.1 Allergan plc Company Information
- 6.10.2 Allergan plc Business Overview
- 6.10.3 Allergan plc Dementia and Alzheimer’s Disease Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Allergan plc Dementia and Alzheimer’s Disease Treatment Product Portfolio
- 6.10.5 Allergan plc Recent Developments
7 North America
- 7.1 North America Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021-2026)
- 7.3 North America Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021-2026)
- 8.3 Europe Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021-2026)
- 10.3 South America Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst